July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter
Jun 14, 2025, 13:43

Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter

The European Society for Medical Oncology (ESMO) shared a post on X:

“Two studies investigating efficacy of bispecific T-cell engager tarlatamab and lurbinectedin – atezolizumab combination met their primary endpoints of survival.
Read the opinion by Alfredo Addeo in the ESMO Daily Reporter․

More posts featuring ESMO Daily Reporter on OncoDaily.